At a glance
ClinicalIndex Comparison RecordN/ACompleted· 19 enrolled
Drug / intervention
E002 - cerumen removal aiddevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Evaluation of a Novel Product for the Removal of Impacted Human Cerumen (Earwax)
In Brief
A clinical study evaluating E002 - cerumen removal aid for Cerumen Impaction of Both Ears. Completed, enrolled 19 participants across 1 site.
Detailed Summary
This is a prospective, open-labeled clinical trial. Subjects that qualify for enrollment and provide informed consent will be treated with a novel topical cerumen (earwax) removal product. The primary goal of this pilot study is to gain an understanding of the safety and efficacy of this novel product.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCerumen Impaction of Both Ears
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20162017201820192020202120222023202420252026
Enrollment StartApr 2016
Primary CompletionMay 2016
Study CompletionJul 2016
First PostedJul 2016
TodayJul 2026
First PostedJul 12, 2016
Enrollment StartApr 1, 2016
Primary CompletionMay 1, 2016
Study CompletionJul 1, 2016
TodayJul 2, 2026
Enrollment to primary: 1 monthPosted 10.0 years ago
Interventions
E002 - cerumen removal aiddevice
topical treatment